Randomized, controlled trial including an initial 4-week daily "induction" period during one year of high-dose interferon alfa-2b treatment for chronic hepatitis C

✍ Scribed by Gonzales, Hernando J.; Ho, Samuel B.; Gross, John B.; Therneau, Terry; Peine, Craig J.; McKee, Daniel; Smith, Teresa

• Book ID: 123065708
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 180 KB
• Volume: 118
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(00)85984-3